{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:05:03Z","timestamp":1792782303200,"version":"4.5.0"},"reference-count":35,"publisher":"Wiley","issue":"19","license":[{"start":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T00:00:00Z","timestamp":1467676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"the Urology Care Foundation Research Scholars Program the American Cancer Society Postdoctoral Fellowship","award":["CPHPS-PF-14-161-01"],"award-info":[{"award-number":["CPHPS-PF-14-161-01"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Urology Care Foundation Research Scholars Program the American Cancer Society Postdoctoral Fellowship","award":["CPHPS-126217-PF-14-028-01"],"award-info":[{"award-number":["CPHPS-126217-PF-14-028-01"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>In the current study, the authors attempted to describe the incidence, most common sites, and mortality of second primary malignancies among survivors of common cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors identified patients aged \u226518 years who were diagnosed with a primary malignancy from the 10 most common cancer sites (prostate, breast, lung, colon, rectum, bladder, uterus, kidney, melanoma, and non\u2010Hodgkin lymphoma) between 1992 and 2008 from Surveillance, Epidemiology, and End Results data. Factors associated with the incidence of second primary malignancies were explored using bivariable and multivariable models, and mortality attributable to first and second primary malignancies was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A cohort of 2,116,163 patients was identified, 170,865 of whom (8.1%) developed a second primary malignancy. Survivors of bladder cancer had the highest risk of developing a second cancer. In a multivariable model controlling for age, race, tumor grade, stage of disease, marital status, educational level, and income, a history of non\u2010Hodgkin lymphoma (hazard ratios of 2.70 and 2.88, respectively, for men and women) and bladder cancer (hazard ratios of 1.88 and 1.66, respectively, for men and women) predicted the highest risk of developing a second cancer. For patients with 2 incident cancers, 13% died of their initial cancer, but greater than one\u2010half (55%) died of their second primary malignancy. Lung cancer was the cause of death in 12% of patients with 2 incident cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      Nearly 1 in 12 patients diagnosed with a common cancer developed a second malignancy, the most common of which was lung cancer. Greater than one\u2010half of patients with 2 incident cancers died of their secondary malignancy. The findings from the current study may inform care strategies among cancer survivors.\n                      <jats:bold>\n                        <jats:italic>Cancer<\/jats:italic>\n                        2016;122:3075\u20103086\n                      <\/jats:bold>\n                      . \u00a9\n                      <jats:italic>2016 American Cancer Society<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.30164","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T11:10:06Z","timestamp":1467717006000},"page":"3075-3086","source":"Crossref","is-referenced-by-count":312,"title":["Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008"],"prefix":"10.1002","volume":"122","author":[{"given":"Nicholas","family":"Donin","sequence":"first","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Filson","sequence":"additional","affiliation":[{"name":"Department of Urology Emory University Atlanta Georgia"},{"name":"Department of Urology Atlanta Veterans Administration Medical Center Decatur Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Drakaki","sequence":"additional","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"},{"name":"Jonsson Comprehensive Cancer Center University of California at Los Angeles Los Angeles California"},{"name":"Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung\u2010Jui","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Castillo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fielding School of Public Health University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"},{"name":"Jonsson Comprehensive Cancer Center University of California at Los Angeles Los Angeles California"},{"name":"Department of Health Policy and Management, Fielding School of Public Health University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[{"name":"Department of Urology, David Geffen School of Medicine University of California at Los Angeles Los Angeles California"},{"name":"Jonsson Comprehensive Cancer Center University of California at Los Angeles Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,7,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"key":"e_1_2_8_3_1","volume-title":"Cancer Treatment & Survivorship Facts & Figures: 2014\u20132015","author":"American Cancer Society","year":"2014"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-1356"},{"key":"e_1_2_8_5_1","volume-title":"Second Cancers and Cardiovascular Disease After Radiation Therapy","author":"National Council on Radiation Protection and Measurements","year":"2011"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.205"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28588"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(92)90475-W"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji278"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv137"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408449109017915"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0309"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70061-4"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm081"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2013.04.008"},{"key":"e_1_2_8_17_1","volume-title":"SEER Cancer Statistics Review, 1975\u20132012","author":"Howlader N","year":"2015"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0782"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc722"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6911.1030"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-013-0278-6"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.3.182"},{"key":"e_1_2_8_23_1","first-page":"149","article-title":"Second cancer following cancer of the urinary system in Connecticut, 1935\u201082","volume":"68","author":"Kantor AF","year":"1985","journal-title":"Natl Cancer Inst Monogr."},{"key":"e_1_2_8_24_1","first-page":"349","article-title":"Second cancer following cancer of the urinary system in Denmark, 1943\u201080","volume":"68","author":"Jensen OM","year":"1985","journal-title":"Natl Cancer Inst Monogr."},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(92)90289-9"},{"issue":"5","key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0022-5347(17)32435-7","article-title":"Bladder cancer and the risk of smoking\u2010related cancers during followup","volume":"152","author":"Salminen E","year":"1994","journal-title":"J Urol."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E"},{"key":"e_1_2_8_28_1","volume-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973\u20102000","author":"Curtis RE","year":"2006"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21234"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21286"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360065034"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.57.2.75"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.000000000000000"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-6-201309170-00690"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2771"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.30164","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.30164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:21:32Z","timestamp":1760296892000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.30164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,5]]},"references-count":35,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1002\/cncr.30164"],"URL":"https:\/\/doi.org\/10.1002\/cncr.30164","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,5]]}}}